PAPER Panza F, Frisardi V, Capurso C, Imbimbo BP, Vendemiale G, Santamato A, D'Onofrio G, Seripa D, Sancarlo D, Pilotto A, Solfrizzi V
SEARCH RESULTS
331209 RESULTS
PAPER Eriksson UK, Sjöberg BG, Bennet AM, de Faire U, Pedersen NL, Frostegård J
Low levels of antibodies against phosphorylcholine in Alzheimer's disease.
J Alzheimers Dis. 2010;21(2):577-84. PubMed: 20571218PAPER Arrieta-Cruz I, Wang J, Pavlides C, Pasinetti GM
Carvedilol reestablishes long-term potentiation in a mouse model of Alzheimer's disease.
J Alzheimers Dis. 2010;21(2):649-54. PubMed: 20571219PAPER Liu SJ, Gasperini R, Foa L, Small DH
Amyloid-beta decreases cell-surface AMPA receptors by increasing intracellular calcium and phosphorylation of GluR2.
J Alzheimers Dis. 2010;21(2):655-66. PubMed: 20571220PAPER Sinning M, van Rooyen JP, Venegas-Francke P, Vásquez C, Behrens MI, Ramírez A
Clinical and genetic analysis of a Chilean family with early-onset autosomal dominant Alzheimer's disease.
J Alzheimers Dis. 2010;21(3):757-61. PubMed: 20571222PAPER Hyttinen L, TuulioHenriksson A, Vuorio AF, Kuosmanen N, Härkänen T, Koskinen S, Strandberg TE
Long-term statin therapy is associated with better episodic memory in aged familial hypercholesterolemia patients in comparison with population controls.
J Alzheimers Dis. 2010;21(2):611-7. PubMed: 20571223PAPER Nicolakakis N, Aboulkassim T, Aliaga A, Tong XK, Rosa-Neto P, Hamel E
Intact memory in TGF-β1 transgenic mice featuring chronic cerebrovascular deficit: recovery with pioglitazone.
J Cereb Blood Flow Metab. 2011 Jan;31(1):200-11. PubMed: 20571524PAPER Marder K
Tarenflurbil in patients with mild Alzheimer's disease.
Curr Neurol Neurosci Rep. 2010 Sep;10(5):336-7. PubMed: 20571933PAPER McArthur RA, Gray J, Schreiber R
Cognitive effects of muscarinic M1 functional agonists in non-human primates and clinical trials.
Curr Opin Investig Drugs. 2010 Jul;11(7):740-60. PubMed: 20571970PAPER Samieri C, Féart C, Proust-Lima C, Peuchant E, Dartigues JF, Amieva H, Barberger-Gateau P
ω-3 fatty acids and cognitive decline: modulation by ApoEε4 allele and depression.
Neurobiol Aging. 2011 Dec;32(12):2317.e13-22. Epub 2010 Jun 8 PubMed: 20570406PAPER Inkster B, Rao AW, Ridler K, Filippini N, Whitcher B, Nichols TE, Wetten S, Gibson RA, Borrie M, Kertesz A, Guzman DA, Loy-English I, Williams J, Saemann PG, Auer DP, Holsboer F, Tozzi F, Muglia P, Merlo-Pich E, Matthews PM
Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's disease.
Neurobiol Aging. 2012 Mar;33(3):457-65. PubMed: 20570408PAPER Chakrabarti E, Ghosh S, Sadhukhan S, Sayre L, Tochtrop GP, Smith JD
Synthesis and biological evaluation of analogues of a novel inhibitor of beta-amyloid secretion.
J Med Chem. 2010 Jul 22;53(14):5302-19. PubMed: 20568779PAPER Bora RP, Prabhakar R
Translational, rotational and internal dynamics of amyloid beta-peptides (Abeta40 and Abeta42) from molecular dynamics simulations.
J Chem Phys. 2009 Oct 21;131(15):155103. PubMed: 20568886PAPER Hampel H
PL01-01- Recent developments in the treatment of Alzheimer disease.
Eur Psychiatry. 2010;25S1:204. PubMed: 20569897New Models for Integrative Care of Alzheimer Disease
WEBINAR 2010-06-25 On 25 June 2010, Ken Kosik, M.D., a neuroscientist at the University of California, Santa Barbara (UCSB), and the executive director of Cognitive Fitness and Innovative Therapies (CFIT), led a Webinar about CFIT, which he describes as "the first full
Current Filters
No filters selected